For pharmacists
For practice administrators
The Need for Quality Initiatives in Oncology

Michael Reff, RPh, MBA, Founder and Executive Director of the National Community Oncology Dispensing Association (NCODA), explains the need for practices and pharmacists to learn about rare cancers so they are better prepared to provide quality patient care. Watch as he discusses the importance of quality initiatives for patients with myeloproliferative neoplasms (MPNs).

For pharmacists
Quality Intervention in Advanced Polycythemia Vera (PV)

Neal Dave, PharmD, Pharmacy Area Manager, Texas Oncology, talks about PV as a hematologic malignancy that may become advanced in a subset of patients despite treatment with hydroxyurea and phlebotomy, resulting in ineffective disease control. 1-4

For pharmacists
For practice administrators
Risk Assessment and Quality Initiatives in Myelofibrosis (MF)

Julianne Orr Darling, PharmD, BCOP, an Oncology and Clinical Pharmacist at Indiana University Health, talks about how risk stratification is an important part of managing patients with MF. Review risk stratification criteria and how pharmacists can create a list of patients for a potential quality initiative. Learn more by watching this video (a downloadable brochure about MF risk is available below as a PDF).

For pharmacists
For practice administrators
Power Point (PPT) Icon

Developing Quality Initiatives

You play an important role in helping to build quality programs for patients living with MPNs. This presentation is intended for US healthcare professionals responsible for population-based decision making at hospitals and US oncology practices.

View Slide Deck
For pharmacists
For practice administrators
PDF Icon

PV Brochure—Brochure Update With New REVEAL Data

Use this downloadable brochure as a resource when implementing a quality intervention for PV.

Download PDF
New
For pharmacists
For practice administrators
PDF Icon

Quality Initiative Implementation Flashcard

Use this flashcard to get an overview of why quality initiatives are important as well as steps for how you can start implementing them in your practice.

Download PDF
New
For pharmacists
For practice administrators
PDF Icon

Cerner EMR Guide for Advanced PV Patient Pursuit List

The Cerner EMR Guide is designed to educate on how to appropriately and proactively identify patients with PV by using EMR data, quality outcomes goals, and NCCN and professional organization guidelines.

Download PDF
For pharmacists
PDF Icon

Symptom Burden Quality Initiative Brochure

View a guide for pharmacy directors and clinical pharmacists that can help clinicians identify patients with burdensome symptoms of MPNs.

Download PDF
New
For pharmacists
For practice administrators
PDF Icon

Epic EMR Guide for Advanced PV Patient Pursuit List

The Epic EMR Guide is designed to educate on how to appropriately and proactively identify patients with PV by using EMR data, quality outcomes goals, and NCCN and professional organization guidelines.

Download PDF
For pharmacists
For practice administrators
PDF Icon

Identifying Risk and Setting Up Quality Treatment Programs for Patients With MF

This brochure provides information that may help you identify and evaluate risk profiles among your patients with MF. This downloadable resource offers insight into strategies for assessing and monitoring risk.

Download PDF
New
For pharmacists
For practice administrators
PDF Icon

Onco EMR Guide for Advanced PV Patient Pursuit List

The Onco EMR Guide is designed to educate on how to appropriately and proactively identify patients with PV by using EMR data, quality outcomes goals, and NCCN and professional organization guidelines.

Download PDF